IDEXX Laboratories, Inc. (IDXX)
USD 404.65
(3.51%)
USD 404.65
(3.51%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 1.77 Billion USD | -16.96% |
| 2022 | 2.13 Billion USD | 22.37% |
| 2021 | 1.74 Billion USD | 5.14% |
| 2020 | 1.66 Billion USD | 0.43% |
| 2019 | 1.65 Billion USD | 6.99% |
| 2018 | 1.54 Billion USD | -12.49% |
| 2017 | 1.76 Billion USD | 7.83% |
| 2016 | 1.63 Billion USD | 5.13% |
| 2015 | 1.55 Billion USD | 23.08% |
| 2014 | 1.26 Billion USD | 77.82% |
| 2013 | 712.3 Million USD | 52.41% |
| 2012 | 467.34 Million USD | -4.86% |
| 2011 | 491.22 Million USD | 52.15% |
| 2010 | 322.86 Million USD | 9.84% |
| 2009 | 293.94 Million USD | -10.17% |
| 2008 | 327.24 Million USD | 24.02% |
| 2007 | 263.85 Million USD | 76.26% |
| 2006 | 149.69 Million USD | 23.35% |
| 2005 | 121.36 Million USD | 4.11% |
| 2004 | 116.57 Million USD | 7.36% |
| 2003 | 108.58 Million USD | 43.48% |
| 2002 | 75.67 Million USD | 6.03% |
| 2001 | 71.37 Million USD | -3.61% |
| 2000 | 74.04 Million USD | -2.44% |
| 1999 | 75.9 Million USD | -8.22% |
| 1998 | 82.7 Million USD | 11.31% |
| 1997 | 74.3 Million USD | 45.12% |
| 1996 | 51.2 Million USD | 53.29% |
| 1995 | 33.4 Million USD | 52.51% |
| 1994 | 21.9 Million USD | 52.08% |
| 1993 | 14.4 Million USD | 54.84% |
| 1992 | 9.3 Million USD | 40.91% |
| 1991 | 6.6 Million USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q3 | 1.73 Billion USD | -5.55% |
| 2024 Q2 | 1.83 Billion USD | 2.8% |
| 2024 Q1 | 1.78 Billion USD | 0.52% |
| 2023 Q4 | 1.77 Billion USD | -0.76% |
| 2023 FY | 1.77 Billion USD | -16.96% |
| 2023 Q3 | 1.78 Billion USD | 0.68% |
| 2023 Q2 | 1.77 Billion USD | -9.68% |
| 2023 Q1 | 1.96 Billion USD | -7.99% |
| 2022 Q1 | 1.95 Billion USD | 11.77% |
| 2022 Q4 | 2.13 Billion USD | -1.2% |
| 2022 FY | 2.13 Billion USD | 22.37% |
| 2022 Q3 | 2.16 Billion USD | 0.65% |
| 2022 Q2 | 2.15 Billion USD | 10.1% |
| 2021 Q2 | 1.66 Billion USD | 2.46% |
| 2021 FY | 1.74 Billion USD | 5.14% |
| 2021 Q4 | 1.74 Billion USD | 7.17% |
| 2021 Q3 | 1.63 Billion USD | -2.02% |
| 2021 Q1 | 1.62 Billion USD | -2.28% |
| 2020 Q4 | 1.66 Billion USD | 3.45% |
| 2020 FY | 1.66 Billion USD | 0.43% |
| 2020 Q3 | 1.6 Billion USD | -4.8% |
| 2020 Q2 | 1.68 Billion USD | -5.11% |
| 2020 Q1 | 1.77 Billion USD | 7.47% |
| 2019 Q3 | 1.54 Billion USD | -0.25% |
| 2019 FY | 1.65 Billion USD | 6.99% |
| 2019 Q4 | 1.65 Billion USD | 6.84% |
| 2019 Q2 | 1.55 Billion USD | -4.69% |
| 2019 Q1 | 1.62 Billion USD | 5.34% |
| 2018 FY | 1.54 Billion USD | -12.49% |
| 2018 Q4 | 1.54 Billion USD | 0.04% |
| 2018 Q3 | 1.54 Billion USD | -1.0% |
| 2018 Q2 | 1.56 Billion USD | 2.84% |
| 2018 Q1 | 1.51 Billion USD | -14.08% |
| 2017 Q1 | 1.64 Billion USD | 0.43% |
| 2017 FY | 1.76 Billion USD | 7.83% |
| 2017 Q4 | 1.76 Billion USD | 2.88% |
| 2017 Q3 | 1.71 Billion USD | -0.32% |
| 2017 Q2 | 1.72 Billion USD | 4.69% |
| 2016 Q4 | 1.63 Billion USD | 13.39% |
| 2016 Q3 | 1.44 Billion USD | -3.5% |
| 2016 FY | 1.63 Billion USD | 5.13% |
| 2016 Q2 | 1.49 Billion USD | -3.52% |
| 2016 Q1 | 1.55 Billion USD | -0.42% |
| 2015 Q3 | 1.51 Billion USD | 3.21% |
| 2015 Q4 | 1.55 Billion USD | 2.83% |
| 2015 Q2 | 1.46 Billion USD | 5.15% |
| 2015 FY | 1.55 Billion USD | 23.08% |
| 2015 Q1 | 1.39 Billion USD | 10.29% |
| 2014 Q4 | 1.26 Billion USD | 19.36% |
| 2014 Q1 | 750.07 Million USD | 5.3% |
| 2014 FY | 1.26 Billion USD | 77.82% |
| 2014 Q3 | 1.06 Billion USD | 27.81% |
| 2014 Q2 | 830.26 Million USD | 10.69% |
| 2013 Q1 | 501.34 Million USD | 7.27% |
| 2013 Q3 | 660.34 Million USD | 7.46% |
| 2013 Q4 | 712.3 Million USD | 7.87% |
| 2013 FY | 712.3 Million USD | 52.41% |
| 2013 Q2 | 614.48 Million USD | 22.57% |
| 2012 FY | 467.34 Million USD | -4.86% |
| 2012 Q1 | 494.22 Million USD | 0.61% |
| 2012 Q2 | 477.37 Million USD | -3.41% |
| 2012 Q4 | 467.34 Million USD | -1.78% |
| 2012 Q3 | 475.81 Million USD | -0.33% |
| 2011 Q1 | 312.57 Million USD | -3.19% |
| 2011 FY | 491.22 Million USD | 52.15% |
| 2011 Q4 | 491.22 Million USD | 28.18% |
| 2011 Q3 | 383.23 Million USD | 12.13% |
| 2011 Q2 | 341.76 Million USD | 9.34% |
| 2010 Q3 | 315.64 Million USD | 2.0% |
| 2010 FY | 322.86 Million USD | 9.84% |
| 2010 Q4 | 322.86 Million USD | 2.29% |
| 2010 Q2 | 309.45 Million USD | -5.41% |
| 2010 Q1 | 327.15 Million USD | 11.3% |
| 2009 Q4 | 293.94 Million USD | -6.76% |
| 2009 FY | 293.94 Million USD | -10.17% |
| 2009 Q3 | 315.25 Million USD | -3.87% |
| 2009 Q2 | 327.93 Million USD | 1.0% |
| 2009 Q1 | 324.67 Million USD | -0.78% |
| 2008 Q4 | 327.24 Million USD | -4.14% |
| 2008 Q3 | 341.36 Million USD | 1.47% |
| 2008 Q2 | 336.42 Million USD | 10.95% |
| 2008 Q1 | 303.22 Million USD | 14.92% |
| 2008 FY | 327.24 Million USD | 24.02% |
| 2007 Q4 | 263.85 Million USD | 3.84% |
| 2007 FY | 263.85 Million USD | 76.26% |
| 2007 Q2 | 261.61 Million USD | 11.61% |
| 2007 Q3 | 254.09 Million USD | -2.88% |
| 2007 Q1 | 234.41 Million USD | 56.59% |
| 2006 FY | 149.69 Million USD | 23.35% |
| 2006 Q1 | 111.99 Million USD | -7.72% |
| 2006 Q2 | 144.34 Million USD | 28.88% |
| 2006 Q3 | 137.38 Million USD | -4.82% |
| 2006 Q4 | 149.69 Million USD | 8.96% |
| 2005 Q4 | 121.36 Million USD | 8.84% |
| 2005 FY | 121.36 Million USD | 4.11% |
| 2005 Q1 | 100.47 Million USD | -13.81% |
| 2005 Q2 | 107.78 Million USD | 7.28% |
| 2005 Q3 | 111.5 Million USD | 3.45% |
| 2004 Q3 | 103.2 Million USD | 4.1% |
| 2004 Q4 | 116.57 Million USD | 12.96% |
| 2004 FY | 116.57 Million USD | 7.36% |
| 2004 Q1 | 96.14 Million USD | -11.46% |
| 2004 Q2 | 99.14 Million USD | 3.12% |
| 2003 FY | 108.58 Million USD | 43.48% |
| 2003 Q4 | 108.58 Million USD | 15.32% |
| 2003 Q1 | 83.56 Million USD | 10.42% |
| 2003 Q3 | 94.16 Million USD | 0.37% |
| 2003 Q2 | 93.81 Million USD | 12.26% |
| 2002 Q4 | 75.67 Million USD | -16.94% |
| 2002 Q2 | 70.25 Million USD | -13.38% |
| 2002 Q1 | 81.1 Million USD | 13.62% |
| 2002 FY | 75.67 Million USD | 6.03% |
| 2002 Q3 | 91.11 Million USD | 29.7% |
| 2001 FY | 71.37 Million USD | -3.61% |
| 2001 Q3 | 74.01 Million USD | 11.1% |
| 2001 Q2 | 66.62 Million USD | 1.8% |
| 2001 Q1 | 65.44 Million USD | -11.62% |
| 2001 Q4 | 71.37 Million USD | -3.57% |
| 2000 Q3 | 87.95 Million USD | 1.05% |
| 2000 Q4 | 74.04 Million USD | -15.81% |
| 2000 Q1 | 72.98 Million USD | -3.84% |
| 2000 FY | 74.04 Million USD | -2.44% |
| 2000 Q2 | 87.03 Million USD | 19.25% |
| 1999 Q2 | 79.7 Million USD | 14.18% |
| 1999 Q4 | 75.9 Million USD | 2.02% |
| 1999 FY | 75.9 Million USD | -8.22% |
| 1999 Q3 | 74.4 Million USD | -6.65% |
| 1999 Q1 | 69.8 Million USD | -15.6% |
| 1998 Q1 | 69 Million USD | -7.13% |
| 1998 Q3 | 58.4 Million USD | -18.44% |
| 1998 Q4 | 82.7 Million USD | 41.61% |
| 1998 FY | 82.7 Million USD | 11.31% |
| 1998 Q2 | 71.6 Million USD | 3.77% |
| 1997 Q4 | 74.3 Million USD | 6.14% |
| 1997 FY | 74.3 Million USD | 45.12% |
| 1997 Q1 | 49.3 Million USD | -3.71% |
| 1997 Q2 | 55.8 Million USD | 13.18% |
| 1997 Q3 | 70 Million USD | 25.45% |
| 1996 FY | 51.2 Million USD | 53.29% |
| 1996 Q4 | 51.2 Million USD | 7.79% |
| 1996 Q2 | 50 Million USD | 39.66% |
| 1996 Q3 | 47.5 Million USD | -5.0% |
| 1996 Q1 | 35.8 Million USD | 7.19% |
| 1995 Q4 | 33.4 Million USD | 4.7% |
| 1995 Q1 | 30.4 Million USD | 38.81% |
| 1995 FY | 33.4 Million USD | 52.51% |
| 1995 Q3 | 31.9 Million USD | -3.63% |
| 1995 Q2 | 33.1 Million USD | 8.88% |
| 1994 Q2 | 22.6 Million USD | 18.32% |
| 1994 Q1 | 19.1 Million USD | 32.64% |
| 1994 FY | 21.9 Million USD | 52.08% |
| 1994 Q4 | 21.9 Million USD | -2.67% |
| 1994 Q3 | 22.5 Million USD | -0.44% |
| 1993 FY | 14.4 Million USD | 54.84% |
| 1993 Q4 | 14.4 Million USD | 2.86% |
| 1993 Q3 | 14 Million USD | 12.9% |
| 1993 Q2 | 12.4 Million USD | 9.73% |
| 1993 Q1 | 11.3 Million USD | 21.51% |
| 1992 Q2 | 9.8 Million USD | 4.26% |
| 1992 Q1 | 9.4 Million USD | 42.42% |
| 1992 Q4 | 9.3 Million USD | 2.2% |
| 1992 FY | 9.3 Million USD | 40.91% |
| 1992 Q3 | 9.1 Million USD | -7.14% |
| 1991 Q3 | 6.6 Million USD | -2.94% |
| 1991 FY | 6.6 Million USD | 0.0% |
| 1991 Q2 | 6.8 Million USD | 0.0% |
| 1991 Q4 | 6.6 Million USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Aspira Women's Health Inc. | 8.62 Million USD | -20479.518% |
| bioAffinity Technologies, Inc. | 3.36 Million USD | -52640.296% |
| Intelligent Bio Solutions Inc. | 5.59 Million USD | -31628.003% |
| Standard BioTools Inc. | 159.86 Million USD | -1010.559% |
| Inotiv, Inc. | 588.04 Million USD | -201.917% |
| Prenetics Global Limited | 44.01 Million USD | -3933.774% |
| Neuronetics, Inc. | 81.64 Million USD | -2074.637% |
| Star Equity Holdings, Inc. | 21.67 Million USD | -8090.98% |
| Castle Biosciences, Inc. | 86.54 Million USD | -1951.484% |
| Psychemedics Corporation | 6.59 Million USD | -26808.078% |
| RadNet, Inc. | 2.07 Billion USD | 14.37% |
| Exact Sciences Corporation | 3.32 Billion USD | 46.621% |
| iSpecimen Inc. | 6.07 Million USD | -29109.896% |
| OpGen, Inc. | 13.44 Million USD | -13105.993% |
| Exagen Inc. | 34.25 Million USD | -5083.635% |
| Bionano Genomics, Inc. | 118.24 Million USD | -1401.429% |
| CareDx, Inc | 223.28 Million USD | -695.118% |
| Check-Cap Ltd. | 1.33 Million USD | -133388.346% |
| Twist Bioscience Corporation | 152.97 Million USD | -1060.609% |
| Guardant Health, Inc. | 1.62 Billion USD | -9.071% |
| Biodesix, Inc. | 94.51 Million USD | -1778.407% |
| BioNexus Gene Lab Corp. | 1.74 Million USD | -101820.501% |
| Precipio, Inc. | 3.67 Million USD | -48249.537% |
| Natera, Inc. | 691.79 Million USD | -156.635% |
| Fulgent Genetics, Inc. | 139.82 Million USD | -1169.745% |
| Sera Prognostics, Inc. | 25.28 Million USD | -6922.09% |
| 23andMe Holding Co. | 206.64 Million USD | -759.144% |
| OPKO Health, Inc. | 622.47 Million USD | -185.214% |
| Personalis, Inc. | 95.65 Million USD | -1755.982% |
| Aclaris Therapeutics, Inc. | 40.22 Million USD | -4313.551% |
| Applied DNA Sciences, Inc. | 8.77 Million USD | -20122.823% |
| T2 Biosystems, Inc. | 62.83 Million USD | -2725.577% |
| Neogen Corporation | 1.44 Billion USD | -23.29% |
| Myriad Genetics, Inc. | 312.9 Million USD | -467.4% |
| ICON Public Limited Company | 7.74 Billion USD | 77.089% |
| NeoGenomics, Inc. | 739.69 Million USD | -140.018% |
| Star Equity Holdings, Inc. | 21.67 Million USD | -8090.98% |
| MDxHealth SA | 121.92 Million USD | -1356.149% |
| Prenetics Global Limited | 44.01 Million USD | -3933.774% |
| Illumina, Inc. | 4.36 Billion USD | 59.336% |
| DarioHealth Corp. | 38.24 Million USD | -4542.162% |
| ENDRA Life Sciences Inc. | 1.09 Million USD | -162013.286% |
| Medpace Holdings, Inc. | 1.09 Billion USD | -61.712% |
| Mainz Biomed B.V. | 12.15 Million USD | -14500.526% |
| Trinity Biotech plc | 83.38 Million USD | -2029.179% |
| Sotera Health Company | 2.68 Billion USD | 33.919% |
| bioAffinity Technologies, Inc. | 3.36 Million USD | -52640.296% |